首页 > 最新文献

Public Health Ethics最新文献

英文 中文
Why Public Health Is Not About Public Goods. 为什么公共卫生不是公共产品?
IF 2 3区 哲学 Q2 ETHICS Pub Date : 2025-11-27 eCollection Date: 2025-11-01 DOI: 10.1093/phe/phaf023
Lovro Savić

According to the Public Goods Account, proposed by Jonny Anomaly, public health activities should only be concerned with the provision of health-related public goods. In this paper, I argue that the Public Goods Account cannot serve as an adequate account of public health activity. The main reason is that its central concept, that of health-related public goods, is itself implausible. I offer two potential understandings of health-related public goods and argue that, on both understandings, the provision of health-related public goods is neither necessary nor sufficient for a public health activity. First, on both understandings, there are plausible examples of public health activities that do not produce health-related public goods. And second, there are examples of non-public health activities that produce health-related public goods.

根据Jonny Anomaly提出的公共产品账户,公共卫生活动应该只涉及提供与健康相关的公共产品。在本文中,我认为公共产品账户不能作为公共卫生活动的充分账户。主要原因是其核心概念——与健康相关的公共产品——本身就不可信。我对与健康相关的公共产品提出了两种可能的理解,并认为,根据这两种理解,提供与健康相关的公共产品对于公共健康活动既不是必要的,也不是充分的。首先,根据这两种理解,存在一些不产生与健康有关的公共产品的公共卫生活动的合理例子。第二,有一些非公共卫生活动产生了与健康有关的公共产品。
{"title":"Why Public Health Is Not About Public Goods.","authors":"Lovro Savić","doi":"10.1093/phe/phaf023","DOIUrl":"10.1093/phe/phaf023","url":null,"abstract":"<p><p>According to the <i>Public Goods Account</i>, proposed by Jonny Anomaly, public health activities should only be concerned with the provision of <i>health-related</i> public goods. In this paper, I argue that the <i>Public Goods Account</i> cannot serve as an adequate account of public health activity. The main reason is that its central concept, that of health-related public goods, is itself implausible. I offer two potential understandings of health-related public goods and argue that, on both understandings, the provision of health-related public goods is neither necessary nor sufficient for a public health activity. First, on both understandings, there are plausible examples of public health activities that do not produce health-related public goods. And second, there are examples of non-public health activities that produce health-related public goods.</p>","PeriodicalId":49136,"journal":{"name":"Public Health Ethics","volume":"18 3","pages":"phaf023"},"PeriodicalIF":2.0,"publicationDate":"2025-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12659739/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145649915","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"哲学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Should Weight be Given Less Weight in Public Health? 在公共卫生中应该减轻体重吗?
IF 2 3区 哲学 Q2 ETHICS Pub Date : 2025-11-14 eCollection Date: 2025-11-01 DOI: 10.1093/phe/phaf021
Cal Paterson

Obesity is a complex chronic illness of adiposity, yet body weight and obesity are routinely conflated in public health wording and policy design. This paper examines a recent recommendation from the Australian College of Nursing (ACN) to combat obesity via the routine collection and discussion of weight and height data of all school-aged children in the country. The obesity-specific ethical framework developed by ten Have and colleagues (2013) has been used to critique the ACN proposal, and to propose a shift away from weighing people, particularly young people, in health promotion activities for obesity.

肥胖是一种复杂的慢性肥胖疾病,然而在公共卫生措辞和政策设计中,体重和肥胖通常被混为一谈。本文研究了澳大利亚护理学院(ACN)最近的一项建议,即通过常规收集和讨论全国所有学龄儿童的体重和身高数据来对抗肥胖。ten Have及其同事(2013)开发的肥胖特定伦理框架已被用于批评ACN提案,并建议在肥胖健康促进活动中不再为人们(特别是年轻人)称重。
{"title":"Should Weight be Given Less Weight in Public Health?","authors":"Cal Paterson","doi":"10.1093/phe/phaf021","DOIUrl":"10.1093/phe/phaf021","url":null,"abstract":"<p><p>Obesity is a complex chronic illness of adiposity, yet body weight and obesity are routinely conflated in public health wording and policy design. This paper examines a recent recommendation from the Australian College of Nursing (ACN) to combat obesity via the routine collection and discussion of weight and height data of all school-aged children in the country. The obesity-specific ethical framework developed by ten Have and colleagues (2013) has been used to critique the ACN proposal, and to propose a shift away from weighing people, particularly young people, in health promotion activities for obesity.</p>","PeriodicalId":49136,"journal":{"name":"Public Health Ethics","volume":"18 3","pages":"phaf021"},"PeriodicalIF":2.0,"publicationDate":"2025-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12617346/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145543643","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"哲学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Privacy, Exploitation and Global Disease Surveillance: Can We Justly Prevent the Next Pandemic? 隐私、剥削和全球疾病监测:我们能公正地预防下一次大流行吗?
IF 2 3区 哲学 Q2 ETHICS Pub Date : 2025-09-01 eCollection Date: 2025-11-01 DOI: 10.1093/phe/phaf014
Anand Sergeant

In light of the COVID-19 pandemic, global health organizations have called for the implementation of robust global disease surveillance systems to recognize and respond to emerging pathogens. These active surveillance technologies would have a significant global benefit by preventing the spread of current pandemics and informing future pandemic responses. In this paper, I examine the extent to which we can sacrifice individuals' privacy through global disease surveillance in order to benefit current and future generations. First, I outline disease surveillance technologies and explain how disease surveillance would occur primarily in low-income, rural communities in the Global South. Next, I outline privacy-related harms that these individuals would experience as a result of disease surveillance. I argue that within our current distributional system for global health resources, pandemic surveillance would impose privacy-related burdens on marginalized communities, who would receive inadequate benefits from these programs. This is unfair because it exploits the worst off in order to benefit individuals in wealthy nations. I conclude that to justifiably implement global disease surveillance, we ought to adopt a 'prioritarian' approach to health distribution. To impose privacy-related burdens on the worst off, we must ensure that they benefit significantly.

鉴于2019冠状病毒病大流行,全球卫生组织呼吁实施强有力的全球疾病监测系统,以识别和应对新出现的病原体。这些主动监测技术将通过防止当前大流行病的传播和为未来的大流行病应对提供信息,对全球产生重大益处。在本文中,我考察了我们可以在多大程度上通过全球疾病监测牺牲个人隐私,以造福今世后代。首先,我概述了疾病监测技术,并解释了疾病监测如何主要在全球南方的低收入农村社区进行。接下来,我概述了这些人因疾病监测而遭受的与隐私相关的伤害。我认为,在我们目前的全球卫生资源分配系统中,流行病监测将给边缘化社区带来与隐私相关的负担,他们将从这些项目中获得不足的利益。这是不公平的,因为它利用最贫穷的人来造福富裕国家的个人。我的结论是,为了合理地实施全球疾病监测,我们应该对卫生分配采取“优先”的方法。为了让最贫穷的人承担与隐私相关的负担,我们必须确保他们能显著受益。
{"title":"Privacy, Exploitation and Global Disease Surveillance: Can We Justly Prevent the Next Pandemic?","authors":"Anand Sergeant","doi":"10.1093/phe/phaf014","DOIUrl":"10.1093/phe/phaf014","url":null,"abstract":"<p><p>In light of the COVID-19 pandemic, global health organizations have called for the implementation of robust global disease surveillance systems to recognize and respond to emerging pathogens. These active surveillance technologies would have a significant global benefit by preventing the spread of current pandemics and informing future pandemic responses. In this paper, I examine the extent to which we can sacrifice individuals' privacy through global disease surveillance in order to benefit current and future generations. First, I outline disease surveillance technologies and explain how disease surveillance would occur primarily in low-income, rural communities in the Global South. Next, I outline privacy-related harms that these individuals would experience as a result of disease surveillance. I argue that within our current distributional system for global health resources, pandemic surveillance would impose privacy-related burdens on marginalized communities, who would receive inadequate benefits from these programs. This is unfair because it exploits the worst off in order to benefit individuals in wealthy nations. I conclude that to justifiably implement global disease surveillance, we ought to adopt a 'prioritarian' approach to health distribution. To impose privacy-related burdens on the worst off, we must ensure that they benefit significantly.</p>","PeriodicalId":49136,"journal":{"name":"Public Health Ethics","volume":"18 3","pages":"phaf014"},"PeriodicalIF":2.0,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12400026/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144994150","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"哲学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Public Health as a Constitutional Principle. 公共卫生作为一项宪法原则。
IF 1.4 3区 哲学 Q2 ETHICS Pub Date : 2025-07-10 eCollection Date: 2025-07-01 DOI: 10.1093/phe/phaf007
Alvin Chen

Public health is commonly regarded as a branch of public policy. While few governments would dispute that public health should be a core responsibility of the state, in practice, it is frequently reduced to a branch of administration, in competition with other branches over annual budget distributions and policy priority. This paper advances the argument that the state should prioritize public health for one crucial reason: public health is a normative principle that constitutes the modern state. As a constitutional principle, it demands the state to promote and preserve public health. The paper examines first what makes public health a normative principle, and then examines why it is a normative principle that makes demands on the state. In so doing, the paper distinguishes public health as a constitutional principle from the constitutional right to health. The paper concludes with a reflection on the urgency to prioritize public health, not merely because of policy needs, but on the ground that it is a foundational normative principle of the modern state.

公共卫生通常被认为是公共政策的一个分支。虽然很少有政府会质疑公共卫生应该是国家的核心责任,但在实践中,它经常被缩减为一个行政部门,与其他部门就年度预算分配和政策优先事项展开竞争。本文提出了国家应该优先考虑公共卫生的一个关键原因:公共卫生是构成现代国家的规范性原则。作为一项宪法原则,它要求国家促进和维护公众健康。本文首先考察了是什么使公共卫生成为一项规范性原则,然后考察了为什么它是一项对国家提出要求的规范性原则。在这样做时,该文件将公共卫生作为一项宪法原则与宪法规定的健康权区分开来。本文最后反思了优先考虑公共卫生的紧迫性,这不仅仅是因为政策需要,而是因为它是现代国家的基本规范原则。
{"title":"Public Health as a Constitutional Principle.","authors":"Alvin Chen","doi":"10.1093/phe/phaf007","DOIUrl":"10.1093/phe/phaf007","url":null,"abstract":"<p><p>Public health is commonly regarded as a branch of public policy. While few governments would dispute that public health should be a core responsibility of the state, in practice, it is frequently reduced to a branch of administration, in competition with other branches over annual budget distributions and policy priority. This paper advances the argument that the state should prioritize public health for one crucial reason: public health is a normative principle that constitutes the modern state. As a constitutional principle, it demands the state to promote and preserve public health. The paper examines first what makes public health a normative principle, and then examines why it is a normative principle that makes demands on the state. In so doing, the paper distinguishes public health as a constitutional principle from the constitutional right to health. The paper concludes with a reflection on the urgency to prioritize public health, not merely because of policy needs, but on the ground that it is a foundational normative principle of the modern state.</p>","PeriodicalId":49136,"journal":{"name":"Public Health Ethics","volume":"18 2","pages":"phaf007"},"PeriodicalIF":1.4,"publicationDate":"2025-07-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12242155/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144610138","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"哲学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ethics of Mathematical Modeling in Public Health: The Case of Medical Male Circumcision for HIV Prevention in Africa. 公共卫生中的数学建模伦理:以非洲男性包皮环切术预防艾滋病毒为例。
IF 2 3区 哲学 Q2 ETHICS Pub Date : 2024-10-14 eCollection Date: 2024-11-01 DOI: 10.1093/phe/phae009
Stuart Rennie, Sara Levintow, Adam Gilbertson, Winnie Kavulani Luseno

Mathematical modelling has played an increasingly prominent role in public health responses, for example by offering estimates of how infectious disease incidence over time may be affected by the adoption of certain policies and interventions. In this paper, we call for greater research and reflection into the ethics of mathematical modeling in public health. First, we present some promising ways of framing the ethics of mathematical modeling that have been offered in the very few publications specifically devoted to this subject. Second, to draw out some issues that have not yet been sufficiently considered, we bring in the case of mathematical modeling in voluntary medical male circumcision (VMMC) initiatives for HIV prevention in Africa. We argue that greater attention should be paid to ethical considerations in mathematical modeling, particularly as its use is becoming more widespread and its potential impacts are becoming greater in the 'big data' era, as witnessed during the COVID-19 pandemic.

数学模型在公共卫生对策中发挥着日益突出的作用,例如,它可以估计采取某些政策和干预措施对传染病发病率的长期影响。在本文中,我们呼吁对公共卫生数学建模的伦理进行更多的研究和反思。首先,我们提出了一些有希望的方法来构建数学建模的伦理,这些方法已经在极少数专门致力于这一主题的出版物中提供。第二,为了找出一些尚未得到充分考虑的问题,我们引入了非洲预防艾滋病毒的自愿医疗男性包皮环切(VMMC)倡议中的数学模型。我们认为,应更多地关注数学建模中的道德因素,特别是在新冠肺炎大流行期间,数学建模的使用越来越广泛,其潜在影响在“大数据”时代变得越来越大。
{"title":"Ethics of Mathematical Modeling in Public Health: The Case of Medical Male Circumcision for HIV Prevention in Africa.","authors":"Stuart Rennie, Sara Levintow, Adam Gilbertson, Winnie Kavulani Luseno","doi":"10.1093/phe/phae009","DOIUrl":"10.1093/phe/phae009","url":null,"abstract":"<p><p>Mathematical modelling has played an increasingly prominent role in public health responses, for example by offering estimates of how infectious disease incidence over time may be affected by the adoption of certain policies and interventions. In this paper, we call for greater research and reflection into the ethics of mathematical modeling in public health. First, we present some promising ways of framing the ethics of mathematical modeling that have been offered in the very few publications specifically devoted to this subject. Second, to draw out some issues that have not yet been sufficiently considered, we bring in the case of mathematical modeling in voluntary medical male circumcision (VMMC) initiatives for HIV prevention in Africa. We argue that greater attention should be paid to ethical considerations in mathematical modeling, particularly as its use is becoming more widespread and its potential impacts are becoming greater in the 'big data' era, as witnessed during the COVID-19 pandemic.</p>","PeriodicalId":49136,"journal":{"name":"Public Health Ethics","volume":"17 3","pages":"125-138"},"PeriodicalIF":2.0,"publicationDate":"2024-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11638778/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142830639","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"哲学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ethical Dimensions of Population-Based Lung Cancer Screening in Canada: Key Informant Qualitative Description Study. 加拿大全民肺癌筛查的伦理问题:关键信息提供者定性描述研究》。
IF 1.4 3区 哲学 Q2 ETHICS Pub Date : 2024-08-29 eCollection Date: 2024-11-01 DOI: 10.1093/phe/phae008
Manisha Pahwa, Julia Abelson, Paul A Demers, Lisa Schwartz, Katrina Shen, Meredith Vanstone

Normative issues associated with the design and implementation of population-based lung cancer screening policies are underexamined. This study was an exposition of the ethical justification for screening and potential ethical issues and their solutions in Canadian jurisdictions. A qualitative description study was conducted. Key informants, defined as policymakers, scientists and clinicians who develop and implement lung cancer screening policies in Canada, were purposively sampled and interviewed using a semi-structured guide informed by population-based disease screening principles and ethical issues in cancer screening. Interview data were analyzed using qualitative content analysis. Fifteen key informants from seven provinces were interviewed. Virtually all justified screening by beneficence, describing that population benefits outweigh individual harms if high-risk people are screened in organized programs according to disease screening principles. Equity of screening access, stigma and lung cancer primary prevention were other ethical issues identified. Key informants prioritized beneficence over concerns for group-level justice issues when making decisions about whether to implement screening policies. This prioritization, though slight, may impede the implementation of screening policies in a way that effectively addresses justice issues, a goal likely to require justice theory and critical interpretation of disease screening principles.

与以人群为基础的肺癌筛查政策的设计和实施相关的规范性问题尚未得到充分审查。本研究是对加拿大司法管辖区筛选和潜在伦理问题及其解决方案的伦理理由的阐述。进行了定性描述研究。主要信息提供者(定义为在加拿大制定和实施肺癌筛查政策的决策者、科学家和临床医生)使用基于人群的疾病筛查原则和癌症筛查中的伦理问题的半结构化指南进行了有目的的抽样和访谈。访谈资料采用定性内容分析法进行分析。采访了来自7个省的15名关键线人。事实上,所有的筛查都是通过慈善来证明的,描述了如果高风险人群根据疾病筛查原则在有组织的项目中进行筛查,那么人群的益处大于个人的危害。筛查机会公平、污名化和肺癌一级预防是确定的其他伦理问题。在决定是否实施筛查政策时,关键举报人优先考虑的是慈善,而不是群体层面的正义问题。这种优先次序虽然轻微,但可能会阻碍筛查政策的实施,从而有效地解决司法问题,这一目标可能需要司法理论和对疾病筛查原则的批判性解释。
{"title":"Ethical Dimensions of Population-Based Lung Cancer Screening in Canada: Key Informant Qualitative Description Study.","authors":"Manisha Pahwa, Julia Abelson, Paul A Demers, Lisa Schwartz, Katrina Shen, Meredith Vanstone","doi":"10.1093/phe/phae008","DOIUrl":"10.1093/phe/phae008","url":null,"abstract":"<p><p>Normative issues associated with the design and implementation of population-based lung cancer screening policies are underexamined. This study was an exposition of the ethical justification for screening and potential ethical issues and their solutions in Canadian jurisdictions. A qualitative description study was conducted. Key informants, defined as policymakers, scientists and clinicians who develop and implement lung cancer screening policies in Canada, were purposively sampled and interviewed using a semi-structured guide informed by population-based disease screening principles and ethical issues in cancer screening. Interview data were analyzed using qualitative content analysis. Fifteen key informants from seven provinces were interviewed. Virtually all justified screening by beneficence, describing that population benefits outweigh individual harms if high-risk people are screened in organized programs according to disease screening principles. Equity of screening access, stigma and lung cancer primary prevention were other ethical issues identified. Key informants prioritized beneficence over concerns for group-level justice issues when making decisions about whether to implement screening policies. This prioritization, though slight, may impede the implementation of screening policies in a way that effectively addresses justice issues, a goal likely to require justice theory and critical interpretation of disease screening principles.</p>","PeriodicalId":49136,"journal":{"name":"Public Health Ethics","volume":"17 3","pages":"139-153"},"PeriodicalIF":1.4,"publicationDate":"2024-08-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11637757/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142830636","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"哲学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
From Self-Management to Shared-Management: A Relational Approach for Equitable Chronic Care 从自我管理到共享管理:公平慢性病护理的关系方法
IF 2.1 3区 哲学 Q2 ETHICS Pub Date : 2024-08-22 DOI: 10.1093/phe/phae007
Francisca Stutzin Donoso
Life with chronic disease and chronic care is hard and people who live in disadvantage may lack the freedom to prioritise their care because of increased competing demands. This paper proposes that shifting the goals of chronic care from self-management support to a shared-management approach can help improve wellbeing and health outcomes across social groups. This work draws on a qualitative exploration of the lived experience of chronic disease and an applied ethical analysis of the reproduction of disadvantages within chronic care. The qualitative results further specify respectful and collaborative patient-healthcare professional relationships; autonomy-supportive interventions; and continuity of care to face the complexity of chronicity in a phenomenological sense—a paradoxical experience of long duration that comprises the disease’s presence in the absence of its manifestation. The ethical analysis draws on performativity; autonomy and decision-making; and responsibility, which constitute the theoretical foundation for shared-management. This approach contributes to advance current normative thinking for health justice and outlines practical steps for its clinical implementation in the delivery of chronic care.
患有慢性疾病和长期护理的人生活艰辛,而生活在弱势群体中的人可能会因为更多相互竞争的需求而无法自由地优先考虑他们的护理。本文提出,将慢性病护理的目标从自我管理支持转向共同管理方法,有助于改善不同社会群体的福祉和健康状况。这项工作借鉴了对慢性病生活体验的定性探索,以及对慢性病护理中的不利因素再现进行的应用伦理分析。定性结果进一步明确了患者与医疗保健专业人员之间相互尊重、相互协作的关系;支持自主性的干预措施;以及从现象学意义上面对慢性病复杂性的连续性护理--一种由疾病存在而疾病不存在的长期矛盾体验。伦理分析借鉴了表演性、自主和决策以及责任,这些构成了共同管理的理论基础。这种方法有助于推进当前的健康正义规范思想,并概述了在提供慢性病护理的临床实施中的实际步骤。
{"title":"From Self-Management to Shared-Management: A Relational Approach for Equitable Chronic Care","authors":"Francisca Stutzin Donoso","doi":"10.1093/phe/phae007","DOIUrl":"https://doi.org/10.1093/phe/phae007","url":null,"abstract":"Life with chronic disease and chronic care is hard and people who live in disadvantage may lack the freedom to prioritise their care because of increased competing demands. This paper proposes that shifting the goals of chronic care from self-management support to a shared-management approach can help improve wellbeing and health outcomes across social groups. This work draws on a qualitative exploration of the lived experience of chronic disease and an applied ethical analysis of the reproduction of disadvantages within chronic care. The qualitative results further specify respectful and collaborative patient-healthcare professional relationships; autonomy-supportive interventions; and continuity of care to face the complexity of chronicity in a phenomenological sense—a paradoxical experience of long duration that comprises the disease’s presence in the absence of its manifestation. The ethical analysis draws on performativity; autonomy and decision-making; and responsibility, which constitute the theoretical foundation for shared-management. This approach contributes to advance current normative thinking for health justice and outlines practical steps for its clinical implementation in the delivery of chronic care.","PeriodicalId":49136,"journal":{"name":"Public Health Ethics","volume":"24 1","pages":""},"PeriodicalIF":2.1,"publicationDate":"2024-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142205073","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"哲学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Application of Australian Rights Protections to the Use of Hepatitis C Notification Data to Engage People ‘Lost to Follow Up’ 澳大利亚权利保护措施在使用丙型肝炎通知数据吸引 "失去随访 "者方面的应用
IF 2.1 3区 哲学 Q2 ETHICS Pub Date : 2024-05-18 DOI: 10.1093/phe/phae006
Freya Saich, Shelley Walker, Margaret Hellard, Mark Stoové, Kate Seear
Hepatitis C is a global public health threat, affecting 56 million people worldwide. The World Health Organization has committed to eliminating hepatitis C by 2030. Although new treatments have revolutionised the treatment and care of people with hepatitis C, treatment uptake has slowed in recent years, drawing attention to the need for innovative approaches to reach elimination targets. One approach involves using existing notifiable disease data to contact people previously diagnosed with hepatitis C. Within these disease surveillance systems, however, competing tensions exist, including protecting individual rights to privacy and autonomy, and broader public health goals. We explore these issues using hepatitis C and Australia’s legislative and regulatory frameworks as a case study. We examine emerging uses of notification data to contact people not yet treated, and describe some of the ethical dilemmas associated with the use and non-use of this data and the protections that exist to preserve individual rights and public health. We reveal weaknesses in rights protections and processes under Australian public health and human rights legislation and argue for consultation with and involvement of affected communities in policy and intervention design before notification data is used to increase hepatitis C treatment coverage.
丙型肝炎是一种全球性的公共健康威胁,影响着全球 5600 万人。世界卫生组织承诺到 2030 年消灭丙型肝炎。虽然新的治疗方法彻底改变了丙型肝炎患者的治疗和护理,但近年来治疗接受率有所放缓,这使人们注意到需要采用创新方法来实现消除丙型肝炎的目标。然而,在这些疾病监测系统中存在着相互竞争的矛盾,包括保护个人隐私和自主权以及更广泛的公共卫生目标。我们以丙型肝炎和澳大利亚的立法与监管框架为案例,探讨了这些问题。我们研究了新出现的使用通知数据来联系尚未接受治疗者的情况,并描述了与使用和不使用这些数据相关的一些道德困境,以及为维护个人权利和公共健康而存在的保护措施。我们揭示了澳大利亚公共卫生和人权立法在权利保护和程序方面的薄弱环节,并主张在使用通知数据提高丙型肝炎治疗覆盖率之前,应与受影响社区进行协商并让其参与政策和干预措施的设计。
{"title":"The Application of Australian Rights Protections to the Use of Hepatitis C Notification Data to Engage People ‘Lost to Follow Up’","authors":"Freya Saich, Shelley Walker, Margaret Hellard, Mark Stoové, Kate Seear","doi":"10.1093/phe/phae006","DOIUrl":"https://doi.org/10.1093/phe/phae006","url":null,"abstract":"Hepatitis C is a global public health threat, affecting 56 million people worldwide. The World Health Organization has committed to eliminating hepatitis C by 2030. Although new treatments have revolutionised the treatment and care of people with hepatitis C, treatment uptake has slowed in recent years, drawing attention to the need for innovative approaches to reach elimination targets. One approach involves using existing notifiable disease data to contact people previously diagnosed with hepatitis C. Within these disease surveillance systems, however, competing tensions exist, including protecting individual rights to privacy and autonomy, and broader public health goals. We explore these issues using hepatitis C and Australia’s legislative and regulatory frameworks as a case study. We examine emerging uses of notification data to contact people not yet treated, and describe some of the ethical dilemmas associated with the use and non-use of this data and the protections that exist to preserve individual rights and public health. We reveal weaknesses in rights protections and processes under Australian public health and human rights legislation and argue for consultation with and involvement of affected communities in policy and intervention design before notification data is used to increase hepatitis C treatment coverage.","PeriodicalId":49136,"journal":{"name":"Public Health Ethics","volume":"210 1","pages":""},"PeriodicalIF":2.1,"publicationDate":"2024-05-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141063381","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"哲学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Time to Treat the Climate and Nature Crisis as One Indivisible Global Health Emergency. 是时候将气候和自然危机视为一个不可分割的全球健康紧急情况了。
IF 1.4 3区 哲学 Q2 ETHICS Pub Date : 2024-03-23 eCollection Date: 2024-04-01 DOI: 10.1093/phe/phad022
Kamran Abbasi, Parveen Ali, Virginia Barbour, Thomas Benfield, Kirsten Bibbins-Domingo, Stephen Hancocks, Richard Horton, Laurie Laybourn-Langton, Robert Mash, Peush Sahni, Wadeia Mohammad Sharief, Paul Yonga, Chris Zielinski
{"title":"Time to Treat the Climate and Nature Crisis as One Indivisible Global Health Emergency.","authors":"Kamran Abbasi, Parveen Ali, Virginia Barbour, Thomas Benfield, Kirsten Bibbins-Domingo, Stephen Hancocks, Richard Horton, Laurie Laybourn-Langton, Robert Mash, Peush Sahni, Wadeia Mohammad Sharief, Paul Yonga, Chris Zielinski","doi":"10.1093/phe/phad022","DOIUrl":"10.1093/phe/phad022","url":null,"abstract":"","PeriodicalId":49136,"journal":{"name":"Public Health Ethics","volume":"17 1-2","pages":"1-4"},"PeriodicalIF":1.4,"publicationDate":"2024-03-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11245690/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141617478","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"哲学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Psychedelics in PERIL: The Commercial Determinants of Health, Financial Entanglements and Population Health Ethics Psychedelics in PERIL:健康的商业决定因素、金融纠葛与人口健康伦理
IF 2.1 3区 哲学 Q2 ETHICS Pub Date : 2024-03-02 DOI: 10.1093/phe/phae002
Daniel Buchman, Daniel Rosenbaum
The nascent for-profit psychedelic industry has begun to engage in corporate practices like funding scientific research and research programs. There is substantial evidence that such practices from other industries like tobacco, alcohol, pharmaceuticals and food create conflicts of interest and can negatively influence population health. However, in a context of funding pressures, low publicly funded success rates and precarious academic labor, there is limited ethics guidance for researchers working at the intersection of clinical practice and population health as to how they should approach potential financial sponsorship from for-profit entities, such as the psychedelic industry. This article reports on a reflective exercise among a group of clinician scientists working in psychedelic science, where we applied Adams’ (2016) PERIL (Purpose, Extent, Relevant harm, Identifiers, Link) ethical decision-making framework to a fictionalized case of corporate psychedelic financial sponsorship. Our analysis suggests financial relationships with the corporate psychedelic sector may create varying degrees of risk to a research program’s purpose, autonomy and integrity. We argue that the commercial determinants of health provide a useful framework for understanding the ethics of industry-healthcare entanglements and can provide an important population health ethics lens to examine nascent industries such as psychedelics, and work toward potential solutions.
新生的以营利为目的的迷幻药行业已经开始参与企业行为,如资助科学研究和研究项目。有大量证据表明,烟草、酒精、药品和食品等其他行业的此类做法会造成利益冲突,并对人口健康产生负面影响。然而,在资金压力大、公共资助成功率低、学术劳动岌岌可危的背景下,对于从事临床实践与人口健康交叉领域工作的研究人员来说,他们应该如何对待来自迷幻药行业等营利性实体的潜在经济赞助,目前的伦理指导还很有限。本文报告了一组从事迷幻剂科学研究的临床科学家的反思活动,我们将亚当斯(2016 年)的 PERIL(目的、范围、相关危害、标识符、联系)伦理决策框架应用于一个虚构的企业迷幻剂财务赞助案例。我们的分析表明,与企业迷幻药部门的财务关系可能会给研究项目的目的、自主性和完整性带来不同程度的风险。我们认为,健康的商业决定因素为理解产业与医疗保健之间的伦理纠葛提供了一个有用的框架,可以为研究迷幻药等新兴产业提供一个重要的人口健康伦理视角,并努力寻找潜在的解决方案。
{"title":"Psychedelics in PERIL: The Commercial Determinants of Health, Financial Entanglements and Population Health Ethics","authors":"Daniel Buchman, Daniel Rosenbaum","doi":"10.1093/phe/phae002","DOIUrl":"https://doi.org/10.1093/phe/phae002","url":null,"abstract":"The nascent for-profit psychedelic industry has begun to engage in corporate practices like funding scientific research and research programs. There is substantial evidence that such practices from other industries like tobacco, alcohol, pharmaceuticals and food create conflicts of interest and can negatively influence population health. However, in a context of funding pressures, low publicly funded success rates and precarious academic labor, there is limited ethics guidance for researchers working at the intersection of clinical practice and population health as to how they should approach potential financial sponsorship from for-profit entities, such as the psychedelic industry. This article reports on a reflective exercise among a group of clinician scientists working in psychedelic science, where we applied Adams’ (2016) PERIL (Purpose, Extent, Relevant harm, Identifiers, Link) ethical decision-making framework to a fictionalized case of corporate psychedelic financial sponsorship. Our analysis suggests financial relationships with the corporate psychedelic sector may create varying degrees of risk to a research program’s purpose, autonomy and integrity. We argue that the commercial determinants of health provide a useful framework for understanding the ethics of industry-healthcare entanglements and can provide an important population health ethics lens to examine nascent industries such as psychedelics, and work toward potential solutions.","PeriodicalId":49136,"journal":{"name":"Public Health Ethics","volume":"20 1","pages":""},"PeriodicalIF":2.1,"publicationDate":"2024-03-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140017119","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"哲学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Public Health Ethics
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1